{
    "success": true,
    "data": {
        "id": 1675257,
        "msgid": "bio-farma-groups-cross-sector-collaboration-expands-global-market-access-1776099046",
        "date": "2026-04-13 23:21:16",
        "title": "Bio Farma Group\u2019s Cross-Sector Collaboration Expands Global Market Access",
        "author": "",
        "source": "ANTARA_ID",
        "tags": "",
        "topic": "Business",
        "summary": "The Bio Farma Group is enhancing health diplomacy through cross-sector collaborations, particularly with the Ministry of Foreign Affairs, to broaden global market access and boost the competitiveness of Indonesia\u2019s national pharmaceutical industry. Company executives emphasise the strategic synergies within the group, which integrate development, production, and distribution to strengthen national health resilience and support Indonesia\u2019s expansion in the global health market. As a state-owned holding with significant production capacity and export reach, Bio Farma reaffirms its commitment to elevating Indonesia\u2019s role as a key global health partner.",
        "content": "<p>Jakarta (ANTARA) - The Bio Farma Group is strengthening health\ndiplomacy through cross-sector collaborations to expand global market\naccess and enhance the competitiveness of the national pharmaceutical\nindustry.<\/p>\n<p>Commercial Director of PT Kimia Farma (Persero) Tbk, Hanadi Setiarto,\nstated that synergy with the Ministry of Foreign Affairs represents a\nstrategic step in opening up global market opportunities.<\/p>\n<p>\u201cThis agenda is a strategic momentum to expand global market access\nwhile strengthening Indonesia\u2019s role in health diplomacy,\u201d said Hanadi\nin his statement in Jakarta on Monday.<\/p>\n<p>He added that the company continues to improve the quality and\nproduction capacity to compete at the international level.<\/p>\n<p>Meanwhile, the Director of Finance and Risk Management of PT Bio\nFarma (Persero), Jeffri Susanto, noted that integration within the Bio\nFarma Group serves as the main strength in enhancing the competitiveness\nof the national pharmaceutical industry.<\/p>\n<p>\u201cAs one ecosystem, the Bio Farma Group possesses complementary\nsynergies, from development and production to distribution,\u201d said\nJeffri.<\/p>\n<p>According to him, this integration also plays a role in strengthening\nnational health resilience while supporting Indonesia\u2019s expansion in the\nglobal health market.<\/p>\n<p>The Bio Farma Group considers cross-sector and cross-country\ncollaborations as key factors in driving the development of the national\npharmaceutical export market.<\/p>\n<p>For information, PT Bio Farma (Persero) is the parent company of the\nstate-owned pharmaceutical holding operating in the life sciences\nsector, with a production capacity of more than 3.4 billion vaccine\ndoses per year and has exported products to more than 150 countries.<\/p>\n<p>In addition, PT Kimia Farma (Persero) Tbk, as part of the holding,\nhas nine production facilities, 44 distribution branches, more than\n1,000 pharmacy networks, more than 350 health clinics, and 65 medical\nlaboratories across Indonesia.<\/p>\n<p>The company affirms its commitment to continuously enhancing product\ncompetitiveness and expanding strategic collaborations to strengthen\nIndonesia\u2019s position as a global health partner.<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/bio-farma-groups-cross-sector-collaboration-expands-global-market-access-1776099046",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}